Refine
Year of publication
Document Type
- Article (95)
- Conference Proceeding (31)
- Part of a Book (13)
- Book (3)
- Other (3)
- Report (2)
- Patent (1)
- Review (1)
Has Fulltext
- no (149) (remove)
Keywords
- Biocomposites (2)
- Limit analysis (2)
- Natural fibres (2)
- Polymer-matrix composites (2)
- Shakedown analysis (2)
- Stress concentrations (2)
- damage (2)
- Anastomotic leakage (1)
- Autolysis (1)
- Bladder (1)
- Bone sawing (1)
- Cardiac myocytes (1)
- Cardiac tissue (1)
- CellDrum (1)
- Chance constrained programming (1)
- Collagen fibrils (1)
- Computational biomechanics (1)
- Connective tissues (1)
- Constitutive model (1)
- Damage mechanics theory (1)
Institute
- IfB - Institut für Bioengineering (149) (remove)
The discovery of human induced pluripotent stem cells reprogrammed from somatic cells [1] and their ability to differentiate into cardiomyocytes (hiPSC-CMs) has provided a robust platform for drug screening [2]. Drug screenings are essential in the development of new components, particularly for evaluating the potential of drugs to induce life-threatening pro-arrhythmias. Between 1988 and 2009, 14 drugs have been removed from the market for this reason [3]. The microelectrode array (MEA) technique is a robust tool for drug screening as it detects the field potentials (FPs) for the entire cell culture. Furthermore, the propagation of the field potential can be examined on an electrode basis. To analyze MEA measurements in detail, we have developed an open-source tool.